This event took place online on February 9. Until our next TPD Webinar, you can register your interest here, or check out more TPD events and content brought to you by Hanson Wade:
Welcome to the TPD: Emerging Disease Applications Beyond Oncology Digital Event!
Targeted protein degradation (TPD) is emerging to be a promising technology for targeting disease-causing proteins. Through the mechanism of hijacking either the ubiquitin-proteasome system (UPS) or the autophagy-lysosomal pathway the protein of interest is degraded, raising hope for the development of treatments targeting previously ''undruggable'' proteins involved in oncology, neurodegeneration, inflammatory and autoimmune disease. TPD has been attracting a lot of attention for cancer treatment with a handful of products making it into clinical trials, however, not much has been available about the progress of TPD besides oncology due to most products currently being found in discovery and pre-clinical stages.
Join to hear insights from experts holding leading positions in biopharma organizations working on TPD. Discover the latest advances in drug discovery and development in areas beyond oncology and get a sense of where the field is heading in the coming years.
Expert speakers will discuss current research in the fields of neurology, inflammatory and autoimmune disease including points concerning degrader type selection, ways to target proteins of interest, the challenges they are facing in proving efficacy and how to overcome them. You will also have the opportunity to ask questions and get high-quality comprehensive answers from speakers.